propionylcarnitine has been researched along with Cardiomyopathies in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Faa, G; Littarru, GP; Mancinelli, R; Vargiu, R | 1 |
| Al-Majed, AA; Al-Rejaie, SS; Al-Shabanah, OA; Al-Yahya, AA; Aleisa, AM; Sayed-Ahmed, MM | 1 |
| Böhles, HJ; Sewell, AC | 1 |
| Abou El-Naga, SA; Calvani, M; Gaballah, HE; Nicolai, R; Salman, TM; Sayed-Ahmed, MM | 1 |
| Comini, L; de Giuli, F; Dhalla, NS; Ferrari, R; Menotti, A; Pasini, E | 1 |
| Cargnoni, A; Condorelli, E; Ferrari, R; Lisciani, R; Marzo, A; Pasini, E | 1 |
| Di Lisa, F; Miotto, G; Pivetta, A; Siliprandi, D; Siliprandi, N | 1 |
2 review(s) available for propionylcarnitine and Cardiomyopathies
| Article | Year |
|---|---|
Acylcarnitines in intermediary metabolism.
Topics: Acylation; Cardiomyopathies; Cardiotonic Agents; Carnitine; Humans; Metabolic Diseases | 1995 |
Transport and function of L-carnitine and L-propionylcarnitine: relevance to some cardiomyopathies and cardiac ischemia.
Topics: Animals; Biological Transport; Cardiomyopathies; Carnitine; Coronary Disease; Humans; Myocardium; Sarcolemma | 1987 |
5 other study(ies) available for propionylcarnitine and Cardiomyopathies
| Article | Year |
|---|---|
Positive inotropic effect of coenzyme Q10, omega-3 fatty acids and propionyl-L-carnitine on papillary muscle force-frequency responses of BIO TO-2 cardiomyopathic Syrian hamsters.
Topics: Animals; Cardiomyopathies; Cardiomyopathy, Dilated; Carnitine; Cricetinae; Fatty Acids, Omega-3; Male; Mesocricetus; Models, Animal; Myocardial Contraction; Papillary Muscles; Stimulation, Chemical; Ubiquinone | 2008 |
Propionyl-L-carnitine prevents the progression of cisplatin-induced cardiomyopathy in a carnitine-depleted rat model.
Topics: Adenosine Triphosphate; Animals; Cardiomyopathies; Carnitine; Cisplatin; Disease Models, Animal; Glutathione; Heart; Male; Myocardium; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances | 2006 |
Propionyl-L-carnitine as protector against adriamycin-induced cardiomyopathy.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cardiomyopathies; Cardiotonic Agents; Carnitine; Doxorubicin; Female; Glutathione; In Vitro Techniques; Male; Malondialdehyde; Mice; Mitochondria, Heart; Oxidation-Reduction; Rats; Rats, Sprague-Dawley | 2001 |
Effect of propionyl-L-carnitine on experimental induced cardiomyopathy in rats.
Topics: Animals; Blood Pressure; Cardiomyopathies; Carnitine; Diabetes Mellitus, Experimental; Erucic Acids; Heart; Hemodynamics; In Vitro Techniques; Male; Rats; Rats, Sprague-Dawley; Reference Values | 1992 |
Effect of prolonged treatment with propionyl-L-carnitine on erucic acid-induced myocardial dysfunction in rats.
Topics: Adenosine Triphosphate; Animals; Cardiomyopathies; Carnitine; Erucic Acids; Heart; Lipid Metabolism; Male; Mitochondria, Heart; Myocardium; Phosphocreatine; Rats; Rats, Inbred Strains | 1992 |